CD36 ‐Mediated Oleic Acid Uptake Drives Tumour‐Associated Macrophage‐Induced Immunosuppression in Hepatocellular Carcinoma
Immunology · 15.11.2026
DOI: 10.1111/imm.70233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, online erschienen am 15.11.2026. Verfasst von Menghua Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Cheelo…. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Taishan Young Scholar Program of Shandong.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) undergoes profound metabolic reprogramming, yet the specific lipid species responsible for driving immunosuppressive remodelling remain unclear. BODIPY 493/503 and Oil Red O staining were used to assess the lipid accumulation in macrophages treated with tumour‐conditioned medium. Immunofluorescence analysis was performed to visualize lipid droplets, while qPCR and flow cytometry were conducted to evaluate the expression of CD36, CD163, CD206 and PD‐L1 on macrophages. Transmission electron microscopy assay was applied to observe mitochondrial morphology and fission. Fatty acid screening was performed to identify the CD36‐mediated signalling pathway. In vivo validation was performed using a DEN/CCl 4 ‐induced HCC mouse model treated with oleic acid alone or in combination with the CD36 inhibitor SSO. We demonstrate that lipid‐rich conditioned medium from HCC cells (HCC‐CM) promotes CD36‐associated intracellular lipid accumulation in tumour‐associated macrophages (TAMs). This lipid accumulation drives M2 polarization, mitochondrial fission and upregulation of PD‐L1 expression in TAMs and is associated with impaired CD8 + T‐cell effector function. Among six representative fatty acids screened, oleic acid emerged as the strongest candidate and recapitulated these effects through CD36‐dependent lipid uptake, mitochondrial remodelling and PD‐L1 upregulation. SSO co‐treatment attenuated these effects both in vitro and in a DEN/CCl 4 ‐induced primary liver cancer model, where it was associated with improved CD8 + T‐cell effector function and reduced tumour growth. Our findings identify oleic acid as a key lipid mediator in TAM reprogramming and highlight CD36 as a potential therapeutic target to restore antitumour immunity in HCC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.
ORCID-Profile: Jian Zhang, Qiuju Han
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Taishan Young Scholar Program of Shandong
- State Key Laboratory of Microbial Technology Open Projects Fund
Zitieren
APA
Li, M., Liu, M., Lin, X., Li, H., Huo, C., Shi, L., Zhao, H., Zhang, J., & Han, Q. (2026). CD36 ‐Mediated Oleic Acid Uptake Drives Tumour‐Associated Macrophage‐Induced Immunosuppression in Hepatocellular Carcinoma. Immunology. https://doi.org/10.1111/imm.70233
Vancouver
Li M, Liu M, Lin X, Li H, Huo C, Shi L, et al. CD36 ‐Mediated Oleic Acid Uptake Drives Tumour‐Associated Macrophage‐Induced Immunosuppression in Hepatocellular Carcinoma. Immunology. 2026. doi:10.1111/imm.70233
BibTeX
@article{Li2026,
author = {Li, Menghua and Liu, Meiyan and Lin, Xinggang and Li, Haohao and Huo, Chenxin and Shi, Lizhi and Zhao, Huajun and Zhang, Jian and Han, Qiuju},
title = {CD36 ‐Mediated Oleic Acid Uptake Drives Tumour‐Associated Macrophage‐Induced Immunosuppression in Hepatocellular Carcinoma},
journal = {Immunology},
year = {2026},
doi = {10.1111/imm.70233}
}
EUVIMED